News and Views on Advances in Neovascular Retinal Disease Treatment: Weighing the Options
News and Views on Advances in Neovascular Retinal Disease Treatment: Weighing the Options is organized by Paradigm Medical Communications, LLC.
Release Date: February 28, 2023
Expiration Date: February 28, 2024
Program Overview:
The use of novel therapy for neovascular retinal diseases continues to be informed by mounting data and clinical experience clarifying benefit/risk profiles and appropriate patient selection, dosing intervals, and switching protocols. In this fast-paced news broadcast, experts will share real-life case studies and review the latest evidence to elucidate pressing clinical questions about novel therapy and guide modern treatment of neovascular retinal diseases in a wide variety of patients.
Learning Objectives:
Upon completion of this activity, participants should be able to:
- Examine the role of pathways beyond VEGF-A that are implicated in the development and progression of neovascular retinal diseases
- Compare the safety, efficacy, and durability of novel treatments with conventional treatments based on pivotal clinical trial data
- Select appropriate therapy for patients with nAMD and DME based on agent and patient characteristics, and with consideration of patient preferences